Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Receivables (2018 - 2025)

Health Catalyst's Receivables history spans 8 years, with the latest figure at $69.2 million for Q4 2025.

  • For Q4 2025, Receivables changed 0.36% year-over-year to $69.2 million; the TTM value through Dec 2025 reached $69.2 million, changed 0.36%, while the annual FY2025 figure was $69.2 million, 0.36% changed from the prior year.
  • Receivables reached $69.2 million in Q4 2025 per HCAT's latest filing, up from $68.6 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $77.1 million in Q2 2025 to a low of $43.3 million in Q1 2022.
  • Average Receivables over 5 years is $57.5 million, with a median of $55.8 million recorded in 2023.
  • Peak YoY movement for Receivables: soared 46.7% in 2023, then fell 9.74% in 2024.
  • A 5-year view of Receivables shows it stood at $49.6 million in 2021, then fell by 1.47% to $48.9 million in 2022, then soared by 32.99% to $65.0 million in 2023, then rose by 6.14% to $69.0 million in 2024, then grew by 0.36% to $69.2 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Receivables are $69.2 million (Q4 2025), $68.6 million (Q3 2025), and $77.1 million (Q2 2025).